About Bonefoam

Peter Cole, MHA, is Executive Vice President of BoneFoam, where he drives organizational growth strategy, commercial partnerships, and innovation pipeline. A foundational leader of the modern BoneFoam, he has spent the better part of a decade scaling the company from an early-stage startup into the category leader in patient positioning — supporting care
across spine, arthroplasty, sports medicine, rehabilitation, anesthesia, OB/GYN, and the broader neuro-musculoskeletal continuum. 

A proud "Double Cane," Peter earned both his B.S. in Biochemistry and Master of Health Administration from the University of Miami. He has co-invented more than 20 commercialized medical devices, contributed to over 45 intellectual property filings, and co-authored publications spanning orthopedics, healthcare delivery, and global health. 

Beyond BoneFoam, Peter serves as Executive Director of Growth Strategy for Scalpel At The Cross, advancing orthopedic care in the Peruvian Amazon, and is a founding partner of et al., a growth and branding platform supporting surgical practices and organizations across the
neuro-musculoskeletal space. Anchored by his work at BoneFoam, Peter's career
commitment is centered on building and scaling the organizations, partnerships,
and innovations that improve patient care and expand access globally.

Clint
McCullough, ATC, OTC leads the internal execution of BoneFoam's commercial and clinical strategy, with enterprise responsibility for how the organization translates vision into operation, through field implementation.A clinician by training, Clint spent more than a decade in direct patient care, clinical research, and surgical first assisting before entering the device industry, holding credentials as both a Certified Athletic Trainer and a Certified Orthopedic Technologist across HealthPartners, Courage Kenny Rehabilitation Institute, and NovaCare Rehabilitation. That grounding remains the source of his authority inside the company, as he has stood on the clinical side of every problem BoneFoam sets out to solve.

Since 2019, Clint has advanced through three roles of increasing scope at BoneFoam, building clinical education and sales enablement into an enterprise capability and leading category launches across multiple specialties. He has led across nearly every function of the organization, and now focuses mostly on building the team and directing the resources behind BoneFoam's continued ascent. He holds a B.S. in Athletic Training from Winona State University. Clint is proud of his farming roots and enjoys fishing, golfing, and Chicago sports.

Ivy Hayden brings 30 years of medical device industry and brings hands on experience in all things operations including procurement, logistics, process development and quality engineering as well as acquisitions and manufacturing transfers. 

Formally educated at Rutgers as a biochemical engineer, Ivy's experience has come from working at large corporations, most recently heading up Global Quality and Operations at Stryker ENT, as well as being part of the successful start-up and
acquisition of Entellus Medical.  

Since starting at BoneFoam in 2025 Ivy has assisted in the relocation to the new corporate headquarters in Minneapolis and has been enjoying working with the team in gaining process efficiencies in quality and operations. 

Dynamic energy. Never-ending curiosity. Simply genuine. Chris Wareham is a business growth executive who believes successful brands are strategically aligned from top to bottom, are hyper focused and think creativity is not a commodity—it’s an advantage.

Through his leadership and brand experiences over the last 27 years, Chris has exceeded profit targets, revenue growth and market share by solving category and business complexities for a wide range of clients as a creative director at renowned Minneapolis advertising agencies. In 2016, Chris co-founded boatBurner, an indie creative agency, to partner with visionary brands who value the power of brave ideas. In November 2023, he left boatBurner to work independently as a consultant with founder-led companies like BoneFoam.

From med-tech and retail to agriculture and consumer packaged goods, his bread and butter is elevating companies to the next level. If you read this so far, congrats. Let me buy you a great cup of coffee. Email me. Ha. Back to more words. His consistent talent for creating balanced ecosystems of left- and right-brain thinkers for a diverse roster of companies, and his deep commitment to achieving amazing results are what makes him stand out in the sea of marketing sameness.

With more than 20 years of experience in finance, accounting, mergers and acquisitions, manufacturing & supply chain, and strategic planning, Sue serves as Director of Financial Strategy and
Optimization. Throughout her career, she has held leadership roles across global organizations and high-growth companies, including 3M, Boston Scientific, and Veeco Instruments, where she specialized in financial planning and analysis, mergers and acquisitions, operational and supply chain finance, and strategic growth initiatives.

At BoneFoam, she leads financial strategy, forecasting, performance management, and long-range planning to support the company's continued growth and commitment to advancing patient and provider safety. Since joining the organization, she has strengthened financial visibility through enhanced forecasting models, corporate performance reporting, and cross-functional decision support while helping build a scalable financial infrastructure to support future expansion.

Driven by a passion for continuous improvement and data-driven decision-making, she partners closely with teams across the organization to ensure resources are aligned with BoneFoam's mission of delivering innovative, high-quality solutions that improve outcomes for healthcare professionals and the patients they serve.

Ben has been working in the medical device industry since 2016 with device experience spanning prototype development for modular airway training manikins and novel endotracheal tubes, system engineering responsibilities on cardiac mapping and ablation systems, and most recently development of novel patient positioning solutions and class 1 medical device operations at BoneFoam. These roles vary from small businesses like 7-Sigma, to a university institution in the Earl E. Bakken Medical Devices Center, to the large fortune 100 company, Abbott Laboratories.

Outside of work, Ben enjoys spending time with his wife and children, making the most of family time together.

Ashlee Danelius brings nearly 20 years of medical device industry experience spanning quality systems, regulatory compliance, risk management, design controls, process validation, manufacturing quality, and leadership. Throughout her career, she has held quality leadership positions with organizations including Teleflex, Biomerics, Abbott Medical, and Boston Scientific.

Since joining BoneFoam Inc. in October 2024, Ashlee has played a key role in strengthening the company's quality and regulatory programs, supporting the achievement of ISO 13485 certification, and advancing compliance initiatives across global markets. She has enjoyed expanding her expertise in Class I medical device regulations worldwide while helping position the organization for continued growth and success.

What Ashlee values most about BoneFoam is its exceptional leadership team and culture. She feels privileged to work alongside dedicated professionals who genuinely care about the products they create and the patients they ultimately serve. As she continues to learn more about BoneFoam's innovative patient positioning solutions and their impact in operating rooms around the world, she remains excited about the company's future and grateful for the opportunity to contribute to its mission of improving patient care through quality, innovation, and service.

By nature, Dr. Cole sees a problem and fixes it.  As an orthopedic surgeon, fracture surgery was his perfect fit; something broken gets fixed and something crooked gets straightened.  Things that make no sense in Dr. Cole’s domain have little chance of survival, and such was the case for patient positioning in surgery at the start of his journey in 1999. Patient setup was inefficient, inconsistent, insufficient, and insulting to common sense—so he set out to change the status quo, and BoneFoam was founded!

Dr. Cole is a Professor in the Department of Orthopedic Surgery at the University of Minnesota, Chairman of the Department at Regions Hospital, and Program Director for the NorthStar Trauma Network. He matriculated from medical school at the University of Miami in 1990, after which time he accomplished both his residency and 1st of two fellowships in ortho-trauma surgery at Brown University.

Subsequently, he fulfilled his 2nd ortho-trauma fellowship at Harborview Medical Center in Seattle at the University of Washington. He is internationally renowned for his work in minimally invasive fracture surgery, the treatment of scapula fractures, and post-traumatic ortho-thoracic conditions. His 290 peer-reviewed publications and 50 book chapters underscore a career of pioneering new frontiers and techniques in the field, and explain the high demand lecture-circuit schedule he carries throughout the world. 

On a personal side, Dr. Cole grew up in Massachusetts, Florida and Caracas, Venezuela which shaped a poly-cultural intelligence which serves him well for his many international initiatives. He is a proud father to his daughter Danielle & two sons Pete Jr and Channing, and a loyal husband to his wife Nancy Elaine of forty-five years.  Peter and Nancy are immersed in humanitarian work through their orthopedic-medical ministry in the Amazon Jungle of Peru, Scalpel At The Cross www.scalpelatthecross.org, which they co-founded in 2004.  This work has become a labor of love for the whole Cole family, and a springboard of rich relationships across many communities. If you can’t find Peter focused on any of these aforementioned passions, he is probably out on the Minnesota trails, cheering for another Titletown Championship ring, or splashing off the coast of New England or South Florida.

Robert (Bob) Korljan, CPA/PFS, brings decades of financial and business advisory experience to the BoneFoam Board of Directors. Throughout his career, he has worked with hundreds of privately held businesses and their owners, helping them better understand their financial performance, identify opportunities for improvement, and develop strategies for sustainable growth and profitability.

Bob has extensive experience in financial analysis, strategic planning, governance, and organizational leadership. In addition to serving on the boards of for-profit companies, he has contributed his expertise to numerous nonprofit organizations, providing oversight and guidance to support their objectives.

Having been involved with BoneFoam for more than eight years, Bob has witnessed the company's growth and innovation in surgical patient positioning technology. He is motivated by BoneFoam's commitment to improving surgical outcomes, enhancing patient safety, and delivering practical solutions that support healthcare professionals. As a board member, Bob helps guide the company's strategic direction, financial stewardship, and long-term growth, while supporting its mission to advance patient care through innovation.

Mark Christopherson is a seasoned medtech executive with more than three decades of leadership across global corporations and venture-backed startups. He joined Lunair Medical as CEO, bringing deep expertise in developing and commercializing breakthrough therapies for sleep apnea and beyond. Previously, Mark was CEO of Cryosa Inc. and a co-founding executive of Inspire Medical Systems, where he led development of its implantable neurostimulation therapy for obstructive sleep apnea. Inspire went public in 2018 and reached a $7.2B market capitalization by 2022. Earlier, Mark helped drive the development of NxThera’s innovative therapy (acquired by Boston Scientific for $406M). His career spans R&D, commercialization, and company building, with a focus on advancing patient care through technology. Mark holds a master’s in Electrical Engineering from the University of Minnesota and a bachelor’s degree in Physics from Bethel University in St. Paul, Minnesota.

John has over 10 years of medical device industry experience in sales management, strategy and product marketing, business development, and
finance. He is currently Vice President of Sales & Marketing at Neurent Medical, a privately held medical device Company pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and safely disrupting hyperactive autonomic nerves that drive underlying inflammation.

John was previously at Tactile Medical leading sales and business development
activities and also as VP of Business Development for Entellus Medical during
their acquisition of Spirox and sale to Stryker and Director of Business
Development and Portfolio Strategy for Stryker ENT including the acquisition of
Arrinex. John started his career at Piper Sandler in the Med Tech investment
banking and capital markets groups. John received his BA from St. Olaf College in Biology and Economics.